DrugsControl Media Services

News Detail

Lilly received marketing authorization for Tirzepatide in India (03-07-2024)

New Delhi, 3 July 2024: The popular weight loss and diabetes drug Tirzepatide  — marketed as Mounjaro and Zepbound in the US —  is likely to hit the markets in India though there has been no confirmation on its launch date.


The drug ha......
View Details

Source : The Indian Express
weight loss drug Tirzepatide Mounjaro Zepbound Drug Controller General of India Indian express news current affairs

Related News